Bio-Rad Laboratories, Inc. (FRA:BUWA)

Market Cap	6.17B -34.8%
Revenue (ttm)	2.20B +0.7%
Net Income	647.21M
EPS	23.72
Shares Out	n/a
PE Ratio	9.54
Forward PE	26.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	8
Open	230.00
Previous Close	230.60
Day's Range	226.60 - 230.00
52-Week Range	187.35 - 294.70
Beta	n/a
RSI	38.54
Earnings Date	Feb 12, 2026

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory e...

• Industry: Laboratory Analytical Instruments
• Founded: 1952
• Employees: 7,450
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BUWA

Financial Performance

Financial numbers in USD